The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

The obesity drug market has experienced a seismic shift in recent years, with Novo Nordisk's (NOV: N) Wegovy (semaglutide) ...

Donald Trump’s tariff move may hit global drug supplies, including top weight loss jabs like Mounjaro and Ozempic, used by ...

German packaging and medical equipment maker Gerresheimer reported a lower organic core profit for the first quarter on ...

British industry leaders fear tariffs imposed by President Trump could disrupt the supply and even the price of drugs ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity now is under attack on multiple fronts, from ...

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

Opportunities lie in the launch of advanced autoinjectors with smart technology and favorable regulatory environments, ...

WeightWatchers is planning to file for bankruptcy after failing to compete against the rise of drug treatments such as ...